ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Vincerx Inc

Vincerx Inc (VINC)

1.30
0.02
(1.56%)
Closed February 17 4:00PM
1.3099
0.0099
(0.76%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

VINC News

Official News Only

VINC Financials

Financials

VINC Discussion

View Posts
Monksdream Monksdream 2 days ago
VINC under $2
👍️0
Invest-in-America Invest-in-America 1 week ago
VINC: But heck, I'd bet that if you indeed DID do that, such would surely entail a person-to-person PHONECON with your WeBull(?) broker, Dude!!
👍️0
Value_Investor Value_Investor 1 week ago
It is Super Hard to understand why this Hidden Gem has $5.4286 per share Huge POSITIVE Book Value but it is trading at such Ridiculous-Low or Huge Discount price levels $1.3x ~ $1.4x?

If I had $3,045,828.80 cash at hand then I'm willing to Buy-Out the Entire OS at current Huge Discount Dirt Cheap price $1.36 because 2,239,580 x $1.36 = $3,045,828.80!



👍️0
Invest-in-America Invest-in-America 2 weeks ago
VINC: THANKS for both heads-ups!!
👍️0
Value_Investor Value_Investor 2 weeks ago
Very Good News just kicked in on After-Hour (see the link below)! Each common share is worthy $6.3226141 based on the Minimal $14.16 Millions dollars Buy-Out deal and 2,239,580 shares Super Tiny OS count!

https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h

So, VINC is Super Undervalued now just like its Red-Hot Bitcoin-Mining peer (VTXB is worthy Multiple Pennies a share at least)! Easy to surge over last-December-high $10.4!

Also, VINC is at Hyper Oversold status (from $187.444 to $1.3101) just like its Red-Hot Bitcoin-Mining peer (from $0.06 to $0.0001)!



👍️0
Value_Investor Value_Investor 2 weeks ago
VINC just hit New Premarket-High $1.83 on the early morning trading session! It will test January 28's Premarket-High $3.35 or even January 16's After-Hour-High $3.502 in the coming days/weeks...

VINC is at Hyper Oversold status now --- from 12/30/2024's high $10.4 to 01/30/2025's low $1.40!

VINC is Extremely Undervalued now based on its Much-Much-Higher Positive Book Value!

Only Mere 2,239,580 shares of the Tiny OS! Easy to surge over $4.00! It is possible for VINC to hit its most recent high $10.4 again!


👍️0
georgie18 georgie18 2 weeks ago
VINC...$1.69...🥳

georgie18

Member Level
Re: None

Saturday, February 01, 2025 3:12:37 PM

Post#
31347
of 31358
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...

georgie18

Member Level
Re: georgie18 post# 31

Wednesday, January 29, 2025 8:28:50 AM

Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 2 weeks ago
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...

georgie18

Member Level
Re: georgie18 post# 31

Wednesday, January 29, 2025 8:28:50 AM

Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
Value_Investor Value_Investor 2 weeks ago
VINC had finally Bottomed Out at New 52-week-low $1.4 yesterday with the After-Hour-high $1.7! It should test January 28's Premarket-High $3.35 or even January 16's After-Hour-High $3.502 in the coming days/weeks...

Note, the most recent high was $10.4!


👍️0
glenn1919 glenn1919 3 weeks ago
VINC............................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 3 weeks ago
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
Invest-in-America Invest-in-America 3 weeks ago
VINC: That news seems impressive.
https://finance.yahoo.com/news/vincerx-pharma-inc-oqory-inc-130000038.html
👍️0
Value_Investor Value_Investor 3 weeks ago
VINC soared to $3.35 so far after Very Good News 9see the link below) from New low $1.62!

https://finance.yahoo.com/news/vincerx-pharma-inc-oqory-inc-130000038.html

This Big-R/S Pos Scam may test $3.502 (i.e. Pre-1:20 R/S's $0.1751) today...

VERY SICK CEO is a Super Crap man and deserves to go to the jail forever!!! Because he has destroyed all the Pre-R/S investors! Never trust this sick man again! Fuck the CEO!!

👍️0
tw0122 tw0122 3 weeks ago
$2.56 *+58% About Proposed Merger
👍️0
tw0122 tw0122 3 weeks ago
You love it today was too quick + 80% $2.90 
👍️0
Invest-in-America Invest-in-America 4 weeks ago
VINC: Love it!!!
👍️0
Value_Investor Value_Investor 4 weeks ago
Wow, VINC bounced up to $0.15 this early morning (01/23/25) and it also bounced up to $0.1751 just a couple of days ago (After-Hour session of 01/16/25)!

It has Very POSITIVE Book Value --- $0.27 per share! So, it is currently Extremely Undervalued! Easy to surge back to $0.3xxx again!

VINC is also at Extremely Oversold status --- from last-month-high $0.52 (12/30/24) to current Ridiculous-Low price levels $0.1xxx!

👍️0
Value_Investor Value_Investor 1 month ago
Why 10-Bagger here? Another New 52-week-low $0.1395 was created yesterday after Heavy Sell-Off and Manipulation Sales! Who have dumped so many shares below its previous 52-week-low $0.1754?

Why VINC crashed from last-month-high $0.52 during the past a couple of weeks? Whoever bought it most recently at $0.52 ~ $0.42 will be never able to make even or make profit in the future!

It seems Bottomed out at $0.1395 anyway!

👍️0
Value_Investor Value_Investor 1 month ago
Another New 52-week-low $0.145 was just created today! We'll see Another New 52-week-low $0.13 as soon as tomorrow...

VINC will be forced to file the Coming Inevitable CH11 or even CH7 BANKRUPTCY very soon! Whoever bought this Pos Scam most recently at $0.52 ~ $0.39 will never have a chance to get positive investment return in the future!

We should see this trash further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the near future!

👍️0
Value_Investor Value_Investor 1 month ago
Another New 52-week-low $0.165 was just created today! We'll see Another New 52-week-low $0.15 as soon as tomorrow...

VINC will be forced to file the Coming Inevitable CH11 or even CH7 BANKRUPTCY very soon! Who ever bought this Pos Scam at $0.52 ~ $0.2 most recently? They are very super stupid!

We should see this trash further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the near future!

👍️0
Value_Investor Value_Investor 1 month ago
The Soon-Bankruptcy Pos Scam declined to $0.1828 (which is just mere $0.0074 higher than its 52-week-low $0.1754) last Friday!

We should see it further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the coming days/weeks...

Note, the WORTHLESS Bitcoin just declined to $90K and will soon crash to $5K!

👍️0
Monksdream Monksdream 1 month ago
Who said every third tier NASDAQ stock was the next MICROSOFT
👍️0
Value_Investor Value_Investor 1 month ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the seventh, eighth, and nineth Bad news for VINC:

"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3095233

"Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3098961

"Up to 1:20 Big R/S" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18036191&guid=Qs0-kKDmXUvnJth

"16,356,210 shares of Huge New FREE dilutions" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18074105&guid=Qs0-kKDmXUvnJth

So, we should see A Series Of New 52-Week-Lows until VINC hits the Final Bottom $0.025...

Are you kidding? "The next Misrosoft|? No way! The best situation is to avoid to file the BANKRUPTCY! I wish "No Bankruptcy" here so that we could see a "Dead-Cat Bounce" sometime this year!

👍️0
Value_Investor Value_Investor 1 month ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the fourth, fifth, and sixth Bad news for VINC:

"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089437

"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3092088

"VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3093920
👍️0
Value_Investor Value_Investor 1 month ago
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the first, second, and third Bad news for VINC:

"Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087853

"VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087906

"STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - VINC, VCSA, MRNS, MHLD" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089161
👍️0
Invest-in-America Invest-in-America 2 months ago
VINC: To dah MOOOOOOOON!!!
👍️0
glenn1919 glenn1919 2 months ago
vinc....................https://stockcharts.com/h-sc/ui?s=vinc&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 2 months ago
We shall see…🥳
👍️0
tedgoeseast tedgoeseast 2 months ago
Got in the mid 30,s after the drop,I wonder if there might be another spike up Monday morning
👍️0
SmokeSignals SmokeSignals 2 months ago
10 bagger imo
👍️0
georgie18 georgie18 2 months ago
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 2 months ago
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 2 months ago
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 3 months ago
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
tw0122 tw0122 4 months ago
VINC .84 + 20% …05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +
👍️0
Laster Laster 10 months ago
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.
👍️0
RAlbert RAlbert 10 months ago
Tomorrow will be $1.50
👍️0
RAlbert RAlbert 10 months ago
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
👍️0
RAlbert RAlbert 10 months ago
Blood bath. I should have waited one more day.
👍️0
Monksdream Monksdream 10 months ago
Somebody knows something you don’t
👍️0
RAlbert RAlbert 10 months ago
I don’t find the price and volume the capital raise is. Am I missing anything here?
👍️0
Monksdream Monksdream 10 months ago
Check for SEC filings
👍️0
RAlbert RAlbert 10 months ago
Is the capital raise 80% discounted to yesterday price? Insane
👍️0
Monksdream Monksdream 10 months ago
Check for a capital raise which means dilution
👍️0
RAlbert RAlbert 10 months ago
Wonder why there is a steep fall in price when the results are not negative.
👍️0
RAlbert RAlbert 10 months ago
Wonder why there is a steep fall in price when the results are not negative.
👍️0
Monksdream Monksdream 11 months ago
VINC 10Q due 4/3
👍️0
Monksdream Monksdream 11 months ago
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
👍️0
Monksdream Monksdream 11 months ago
VINC new 52.week hi
👍️0
Monksdream Monksdream 11 months ago
VINC new 52 week high
👍️0